Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich.

Pennel KAF, Hatthakarnkul P, Wood CS, Lian GY, Al-Badran SSF, Quinn JA, Legrini A, Inthagard J, Alexander PG, van Wyk H, Kurniawan A, Hashmi U, Gillespie MA, Mills M, Ammar A, Hay J, Andersen D, Nixon C, Rebus S, Chang DK, Kelly C, Harkin A, Graham J, Church D, Tomlinson I, Saunders M, Iveson T, Lannagan TRM, Jackstadt R, Maka N, Horgan PG, Roxburgh CSD, Sansom OJ, McMillan DC, Steele CW, Jamieson NB, Park JH, Roseweir AK, Edwards J

Open source

DOI
10.1186/s13046-026-03811-6
Published
2026 Aug 15
Container
Journal of experimental & clinical cancer research : CR
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13046-026-03811-6,
  title = {Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich.},
  author = {Pennel KAF and Hatthakarnkul P and Wood CS and Lian GY and Al-Badran SSF and Quinn JA and Legrini A and Inthagard J and Alexander PG and van Wyk H and Kurniawan A and Hashmi U and Gillespie MA and Mills M and Ammar A and Hay J and Andersen D and Nixon C and Rebus S and Chang DK and Kelly C and Harkin A and Graham J and Church D and Tomlinson I and Saunders M and Iveson T and Lannagan TRM and Jackstadt R and Maka N and Horgan PG and Roxburgh CSD and Sansom OJ and McMillan DC and Steele CW and Jamieson NB and Park JH and Roseweir AK and Edwards J},
  year = {2026},
  journal = {Journal of experimental \& clinical cancer research : CR},
  doi = {10.1186/s13046-026-03811-6},
  url = {https://doi.org/10.1186/s13046-026-03811-6}
}

RIS

TY  - JOUR
TI  - Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich.
AU  - Pennel KAF
AU  - Hatthakarnkul P
AU  - Wood CS
AU  - Lian GY
AU  - Al-Badran SSF
AU  - Quinn JA
AU  - Legrini A
AU  - Inthagard J
AU  - Alexander PG
AU  - van Wyk H
AU  - Kurniawan A
AU  - Hashmi U
AU  - Gillespie MA
AU  - Mills M
AU  - Ammar A
AU  - Hay J
AU  - Andersen D
AU  - Nixon C
AU  - Rebus S
AU  - Chang DK
AU  - Kelly C
AU  - Harkin A
AU  - Graham J
AU  - Church D
AU  - Tomlinson I
AU  - Saunders M
AU  - Iveson T
AU  - Lannagan TRM
AU  - Jackstadt R
AU  - Maka N
AU  - Horgan PG
AU  - Roxburgh CSD
AU  - Sansom OJ
AU  - McMillan DC
AU  - Steele CW
AU  - Jamieson NB
AU  - Park JH
AU  - Roseweir AK
AU  - Edwards J
PY  - 2026
JO  - Journal of experimental & clinical cancer research : CR
DO  - 10.1186/s13046-026-03811-6
UR  - https://doi.org/10.1186/s13046-026-03811-6
ER  - 

APA

KAF, P., P, H., CS, W., GY, L., SSF, A., JA, Q., A, L., J, I., PG, A., H, V. W., A, K., U, H., MA, G., M, M., A, A., J, H., D, A., C, N., S, R., DK, C., C, K., A, H., J, G., D, C., I, T., M, S., T, I., TRM, L., R, J., N, M., PG, H., CSD, R., OJ, S., DC, M., CW, S., NB, J., JH, P., AK, R., & J, E. (2026). Correction: JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal‑rich.. Journal of experimental & clinical cancer research : CR. https://doi.org/10.1186/s13046-026-03811-6

Source records